ArticleBlood advances2017

Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT.

Vincent T Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.